AEON Biopharma, Inc. (AEON)
AMEX · Common · CUSIP 00791X100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AEON and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
00791X100
IPO
2/9/2021 · $10.00/unit
Previous Symbol
PMGU (changed 7/24/2023)
Previous Name
Priveterra Acquisition Corp
Business: AEON Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, or ABP-450, for debilitating medical conditions, with an initial focus on the neurosciences market.

Company Contact

CEO
Marc Forth
CFO
Peter Reynolds
Headquarters
5 Park Plaza, Suite 1750, Irvine, CA 92614
Phone
949-354-6499
Investor Relations
Laurence Watts, New Street IR · 619-916-7620 · laurence@newstreetir.com
SEC EDGAR Filings
View filings »